151 related articles for article (PubMed ID: 24155054)
1. Ezrin expression is an independent prognostic factor in gastro-intestinal cancers.
Arumugam P; Partelli S; Coleman SJ; Cataldo I; Beghelli S; Bassi C; Wijesuriya N; Aleong JA; Froeling FE; Scarpa A; Kocher HM
J Gastrointest Surg; 2013 Dec; 17(12):2082-91. PubMed ID: 24155054
[TBL] [Abstract][Full Text] [Related]
2. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
3. Ezrin expression and cell survival regulation in colorectal cancer.
Leiphrakpam PD; Rajput A; Mathiesen M; Agarwal E; Lazenby AJ; Are C; Brattain MG; Chowdhury S
Cell Signal; 2014 May; 26(5):868-79. PubMed ID: 24462708
[TBL] [Abstract][Full Text] [Related]
4. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY
Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886
[TBL] [Abstract][Full Text] [Related]
5. Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection.
Okamura D; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Miyazaki M
Mod Pathol; 2008 Jul; 21(7):847-55. PubMed ID: 18425081
[TBL] [Abstract][Full Text] [Related]
6. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of ezrin expression in human hepatocellular carcinoma.
Kang YK; Hong SW; Lee H; Kim WH
Mol Carcinog; 2010 Sep; 49(9):798-804. PubMed ID: 20572160
[TBL] [Abstract][Full Text] [Related]
8. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer.
Jin T; Jin J; Li X; Zhang S; Choi YH; Piao Y; Shen X; Lin Z
BMC Cancer; 2014 Mar; 14():191. PubMed ID: 24629131
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.
Aikawa A; Fujita H; Kosaka T; Minato H; Kiyokawa E
Cancer Sci; 2019 Aug; 110(8):2667-2675. PubMed ID: 31175699
[TBL] [Abstract][Full Text] [Related]
11. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.
Kobori T; Tameishi M; Tanaka C; Urashima Y; Obata T
PLoS One; 2021; 16(5):e0250889. PubMed ID: 33974673
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
[TBL] [Abstract][Full Text] [Related]
15. Expression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testis.
Wakayama T; Nakata H; Kurobo M; Sai Y; Iseki S
J Histochem Cytochem; 2009 Apr; 57(4):351-62. PubMed ID: 19064715
[TBL] [Abstract][Full Text] [Related]
16. Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.
Bartova M; Hlavaty J; Tan Y; Singer C; Pohlodek K; Luha J; Walter I
Clin Exp Metastasis; 2017 Jun; 34(5):333-344. PubMed ID: 28624994
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical negative expression of ezrin predicts poor prognosis in clear cell renal cell carcinoma.
Ferrari MVO; da Costa WH; Matushita MAM; Meduna RR; Brazao ES; Bezerra SM; da Cunha IW; Zequi SC
Urol Oncol; 2020 Mar; 38(3):75.e1-75.e7. PubMed ID: 31648868
[TBL] [Abstract][Full Text] [Related]
18. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
19. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
20. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]